Finasteride has long been a popular choice for millions of people seeking to achieve thicker hair. It was marketed as a ...

Biopharmaceutical company Veradermics announced this week that it has secured financing for the phase three trials it needs to get FDA approval for a drug, currently known as VDPHL01, that would be ...

Finasteride, a widely-used treatment for hair loss, has been linked with depression and suicide for over 20 years | Drug ...

Finasteride, a common hair-loss drug, has long been tied to depression and suicide, but regulators ignored the warnings. Prof ...

A popular hair-loss drug may have dangerous mental health effects long dismissed by authorities. Scientists now demand urgent ...

A Hebrew University researcher calls for finasteride removal from the market after finding that many may have died by suicide ...

New Israeli research suggests finasteride, a common baldness drug, poses significant mental health risks, including depression and suicidal thoughts. Experts urge regulatory bodies to reassess its ...

Despite warnings dating back to 2002, the FDA only added depression as a potential side effect in 2011 and suicidal ideation in 2022.

Last week marked the 25-year anniversary of the Food and Drug Administration’s approval of Mifepristone. It comes at a time when reproductive health care rights are under attack by federal ...

Buprenorphine sublingual tablet is prescribed to treat opioid use disorder in two phases: an induction phase to manage initial withdrawal symptoms and a maintenance phase for long-term treatment. You ...

The White House announced a new direct-to-consumer drug sale website called TrumpRx, which Pfizer will participate in with drug discounts. The TrumpRx website is expected to launch by early 2026.

President Trump’s strategy to lower prescription drug prices will be put to the test as drugmakers must now commit to the terms of his “Most Favored Nation” pricing plan or face unspecified actions ...